<DOC>
	<DOCNO>NCT01979926</DOCNO>
	<brief_summary>The Purpose A Multicenter , Randomized , Double-blind , Placebo-controlled Evaluate Efficacy , Safety Pharmacokinetics N02RS1 600mg 1,200mg per day Patients With acute acute exacerbation chronic bronchitis 7 day .</brief_summary>
	<brief_title>Comparative Evaluate Efficacy Acute Chronic Bronchitis</brief_title>
	<detailed_description />
	<mesh_term>Bronchitis</mesh_term>
	<mesh_term>Acute Disease</mesh_term>
	<mesh_term>Bronchitis , Chronic</mesh_term>
	<criteria>Patients 18 , 75 year age Patients Acute Chronic Bronchitis Patients gotten glucocorticoid treatment within 4 week . Patients need treatment antibiotic acute bronchitis infection . Patients gotten teatments antibiotic , bronchodilator , painkiller secretagog within 7 day . Bronchial asthma patient . Patients indication bleed . Patients serious heart renal disease liver ailment immunosuppressive response . Patients history 3 phage Chronic obstructiv lung disease Bronchiectasis patient .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>May 2014</verification_date>
</DOC>